Form 8-K - Current report:
SEC Accession No. 0000950170-24-131263
Filing Date
2024-11-27
Accepted
2024-11-27 08:39:22
Documents
12
Period of Report
2024-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20241126.htm   iXBRL 8-K 44102
2 EX-99.1 agen-ex99_1.htm EX-99.1 16174
  Complete submission text file 0000950170-24-131263.txt   176369

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20241126.xsd EX-101.SCH 23893
14 EXTRACTED XBRL INSTANCE DOCUMENT agen-20241126_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 241506492
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)